Mutational Landscape and Antiproliferative Functions of ELF Transcription Factors in Human Cancer

Area of Science:

• Molecular biology
• Cancer research
• Genetics

Background:

• The ETS transcription factor family plays diverse roles in cellular processes.
• ELF4's oncogenic role is known in blood cancers, but its function in epithelial tumors is unclear.
• Understanding ELF4's function is crucial for identifying new cancer therapeutic targets.

Purpose of the Study:

• To investigate the role of ELF4 in epithelial tumors.
• To identify ELF4 mutations and their functional consequences in human cancers.
• To elucidate the molecular mechanisms underlying ELF4's tumor-suppressive activity.

Main Methods:

• Identification of ELF4 mutations in oral squamous cell carcinoma.
• Functional assays assessing cell proliferation and tumor xenograft growth upon ELF4 restoration.
• Analysis of ELF1 and ELF2 mutations across human cancers.
• Chromatin immunoprecipitation coupled with high-throughput sequencing (ChIP-seq) to identify ELF4-binding sites.
• Mechanistic studies to determine downstream targets of ELF4.

Main Results:

• ELF4 acts as a tumor suppressor in epithelial cancers, with inactivating mutations found in various human tumors.
• Restoration of wild-type ELF4 inhibited cell proliferation and tumor growth.
• Closely related factors ELF1 and ELF2 also showed antiproliferative effects, with mutations being largely mutually exclusive.
• ELF4 directly regulates genes involved in cell-cycle control and apoptosis, including HRK and DLX3.
• A novel cancer subtype characterized by inactivating mutations in the ELF subfamily was identified.

Conclusions:

• Inactivating mutations in the ELF subfamily of transcription factors represent a novel mechanism in human carcinogenesis.
• ELF4 and its family members function as tumor suppressors in epithelial cancers.
• Targeted restoration of ELF function may offer therapeutic benefits in specific cancer settings.